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In this study, 47 staphylococcal strains, isolated from milk of mastitic cattle from Brazilian dairy herds,
were tested for antimicrobial substance (AMS) production. Fourteen strains were shown to produce AMS.
Most AMS were sensitive to proteolytic enzymes, suggesting that they might be bacteriocin-like inhib-
itory substance (BLIS). BLIS 4059, 4231, 4244, 5409, and 5580 exhibited a broad spectrum of activity and,
therefore, were selected for further studies. The ﬁve BLISþ strains were identiﬁed to the species level:
4059 and 4231 as Staphylococcus aureus, 4244 and 5409 as Staphylococcus hyicus, and 5580 as Staphy-
lococcus epidermidis. Cross-immunity analysis and detection of the aurABCD operon by PCR and DNA/
DNA hybridization revealed that strains 4059 and 4231 produce BLIS either identical or similar to aur-
eocin A70 and encoded on plasmids with a size similar to that of pRJ6 (7.9 kb). A structural gene similar
to those of epidermin and Bsa was detected in the genome of strain 5409. The BLISþ strains 4244 and
5580 produce BLIS that seem to be distinct from the best characterized staphylococcal bacteriocins
described in the literature. The BLIS produced by S. hyicus 4244, hyicin 4244, had the ability to inhibit all
30 strains tested as targets, including food-borne pathogens, such as Listeria monocytogenes and S. aureus.
Both pathogens were also inhibited in a food matrix, suggesting that hyicin 4244 has potential
biotechnological application as a food biopreservative.
 2012 Elsevier Ltd. Open access under the Elsevier OA license. 1. Introduction
Milk and dairy products are important components of a healthy
diet, although, if consumed unpasteurized, they can also represent
a health hazard due to possible contamination by pathogenic
bacteria. A study released by CDC in February 2012 examined the
number of dairy outbreaks in the United States between 1993 and
2006, and 60% of them were linked to raw milk products (Langer
et al., 2012). Bovine mastitis is the disease that has the most
signiﬁcant impact on milk quality, since it is the most prevalent
disease in dairy cattle worldwide (LeJeune & Rajala-Schultz, 2009).
Bovine mastitis results in signiﬁcant ﬁnancial costs to the dairy
industry due to decreased milk production and quality, discarded
milk, drugs, veterinarian labor, culling, and occurrence of other
diseases (Bradley, 2002; Huijps, Lam, & Hogeveen, 2008; Viguier,
Arora, Gilmartin, & O’Kennedy, 2009)..
stos2@yahoo.com.br (M.C.F.
he Elsevier OA license. Although several bacterial pathogens can cause mastitis,
Staphylococcus aureus is generally the most important etiologic
agent in mastitis of cows and female buffaloes (Kumar, 2009; Olde
Riekerink, Barkema, Kelton, & Scholl, 2008; Piccinini, Borromeo, &
Zecconi, 2010). Moreover, S. aureus is probably the most infec-
tious agent because it causes a chronic and deep infection in the
mammary glands that is extremely difﬁcult to eradicate (Brouillette
& Malouin, 2005). Coagulase-negative staphylococci (CoNS) have
traditionally been considered to be minor mastitis pathogens.
However, the signiﬁcance of CoNS needs to be reconsidered as they
have become the most common subclinical mastitis-causing agents
in many countries. CoNS can cause persistent infections that can
result in damage to the udder tissue, which leads to decreased milk
production. Staphylococcus simulans and Staphylococcus chromo-
genes are currently the predominant CoNS species involved in
bovine mastitis. Staphylococcus haemolyticus and Staphylococcus
epidermidis also represent important pathogens associated to this
disease (Pyörälä & Taponen, 2009; Schukken et al., 2009; Simojoki,
Hyvönen, Plumed Ferrer, Taponen, & Pyörälä, 2012).
Two traditional strategies used against bacterial diseases in
farms are vaccination and antibiotic treatment. However, the
A.F.S. Duarte et al. / Food Control 32 (2013) 313e321314indiscriminate use of antibiotics can contribute to the emergence of
antibiotic-resistant pathogens, which can be transmitted to the
consumers by milk. In addition, this treatment may contaminate
the milk with residual antibiotics for some days after their
administration, causing problems for consumers (Brito & Lange,
2005; Sawant, Sordillo, & Jayarao, 2005). Thus, the identiﬁcation
of alternative methods for controlling mastitis is essential. One of
these methods could be the use of bacteriocins (Bac).
Bacteriocins are antimicrobial peptides or proteins produced by
bacteria which have inhibitory or bactericidal activity against other
bacteria (Heng, Wescombe, Burton, Jack, & Tagg, 2007; Jack, Tagg, &
Ray, 1995). The bacteriocin-producing strains are immune to their
ownproducts and this immunity is conferred by an immune system
which is generally expressed concomitantly with the bacteriocin
structural genes (Bastos, Ceotto, Coelho, & Nascimento, 2009; Heng
et al., 2007). Bacteriocins possess potential biotechnological appli-
cation as food preservatives since they are effective against key
pathogens of importance in food-borne illnesses, including Listeria
monocytogenes, an important pathogenic bacterium common in the
environment and difﬁcult to control in foods (Gálvez, Abriouel,
López, & Omar, 2007). Moreover, they are generally recognized as
safe, non-toxic on eukaryotic cells and become inactivated by
digestive proteases, having little inﬂuence on the gut microbiota
(Gálvez et al., 2007). Additionally, the bacteriocins can be used for
the treatment andprevention of somebacterial infections, including
bovinemastitis (Coelhoet al., 2007;Gálvez et al., 2007;Klostermann
et al., 2010).
Staphylococcal strains can produce bacteriocins, known as
staphylococcins. S. epidermidis and S. aureus are themost important
staphylococcin producers investigated so far. In S. epidermidis, some
staphylococcins have been characterized, such as the lantibiotics
epidermin (Augustin et al., 1992), Pep 5 (Ersfeld-Dressen, Sahl, &
Brandis, 1984), epilancin K7 (van de Kamp et al., 1995), and epi-
cidin 280 (Heidrich et al., 1998), and the class II bacteriocin epi-
dermicin NI01, which is related to aureocin A53 (Sandiford & Upton,
2012). Epidermin and its variants seem to be the most frequently
produced lantibiotics in the group of CoNS, being reisolated many
times from strains of S. epidermidis and also from other staphylo-
coccal species (Bastos et al., 2009). Nukacin 3299 is a lantibiotic
produced by S. simulans 3299, which is identical to nukacin ISK-1
produced by Staphylococcus warneri (Ceotto et al., 2010). Other
well characterized staphylococcins are produced by S. aureus, such
as aureocin A70 (Netz et al., 2001), aureocin A53 (Netz et al., 2002),
and staphylococcin C55 (Navaratna, Sahl, & Tagg, 1998). Recently,
a novel epidermin-like lantibiotic (Bsa) produced by S. aureus has
been reported (Daly et al., 2010).Table 1
Staphylococcal strains previously described and used in this study.
Strains Relevant features
S. aureus A53 Bacþ (aureocin A53); pRJ9 (10.4 kb)
S. aureus A70 Bacþ (aureocin A70); pRJ6 (7.9 kb)
S. aureus A70 Bac Strain A70 cured of pRJ6
S. aureus C55 Bacþ (staphylococcin C55); pC55 (32 kb)
S. epidermidis Tü3298 Bacþ (epidermin); pTü32 (54 kb)
S. epidermidis K7 Bacþ (epilancin K7)
S. epidermidis 5 Bacþ (Pep5); pED503 (20 kb)
S. epidermidis 5 Bac Strain 5 cured of pED503
S. epidermidis BN280 Bacþ (epicidin 280); pCHO1 (>40 kb)
S. simulans 3299 Bacþ (nukacin 3299); pRJ97 (>25 kb)
S. aureus COL1881 Bacþ (Bsa)
S. aureus MB32 Bacþ; pSH2 (15 kb), pRJ6 (7.9 kb), pRJ5 (2.5 kb)
S. aureus MB196 Bacþ; pRJ15 (27 kb), pRJ10 (10.4 kb), pRJ16 (4.4 kb)
pRJ17 (1.2 kb)
Bacþ, bacteriocin production; Bac, no bacteriocin production.In the present work, bacteriocin production was investigated in
Staphylococcus spp. strains isolated from milk of cows and female
buffaloes with bovine mastitis in different Brazilian dairy herds
aiming to ﬁnd new staphylococcins with potential biotechnological
applications. In the course of this study, a new bacteriocin-like
inhibitory substance (BLIS), named hyicin 4244, was detected and
its action against S. aureus and L. monocytogenes in skimmed milk
was tested.
2. Materials and methods
2.1. Bacterial strains and growth conditions
Staphylococcus spp. strains isolated frommilk of either cows (35)
or female buffaloes (12), all with bovine mastitis, from 33 different
dairy herds located in the southeast region of Brazil, were tested for
antimicrobial substance (AMS) production.
Other staphylococcal strains from previous studies were
employed in the present work either as bacteriocin producers or as
targets in the assay of cross-immunity, and as controls for the
presence of bacteriocin-structural genes. These strains aredescribed
in Table 1.
The staphylococcal strains and the other bacteria used as
targets, with exception of the lactic acid bacteria (LAB), were
cultivated in either BHI (Difco, Sparks, USA) or TSB (Difco) at 37 C
for 18 h and stored in TSB with 40% glycerol (w/v) at 20 C. The
LAB strains were cultivated in MRS (Difco) at either 30 C or 37 C
for 18 h. When necessary, the media were supplemented with agar
at 1.5% (w/v) or 0.6% (w/v).
2.2. Identiﬁcation of the strains
The staphylococcal strains that exhibited AMS production were
identiﬁed to the species level based on Gram staining followed by
the use of a commercial kit for bacterial identiﬁcation (API Staph,
BioMérieux, Marcy-l’Etoile, France) and conventional biochemical
tests (Bannerman & Peacock, 2007). The identiﬁcation of the
staphylococcal strain 4244 was also conﬁrmed by 16S rDNA
sequencing as described by Fagundes et al. (2011).
2.3. Assay for antimicrobial substance production
The investigation of AMS production was performed on BHI
medium using the deferred-antagonism assay as previously
described by Giambiagi-deMarvaL, Mafra, Penido, and Bastos
(1990). Corynebacterium ﬁmi NCTC 7547, which is highly sensitiveBacteriocin structural
genes
Reference
aucA Netz et al., 2002
aurABCD Netz et al., 2001
e Giambiagi-deMarvaL et al., 1990
sacaA and sacbA Navaratna et al., 1998
epiA Allgaier, Jung, Werner, Schneider,
& Zähener, 1986
elkA van de Kamp et al., 1995
pepA Ersfeld-Dressen et al., 1984
- Ersfeld-Dressen et al., 1984
eciA Heidrich et al., 1998
nukA Ceotto et al., 2010
bsaA2 Daly et al., 2010
aurABCD Ceotto et al., 2009
, aucA Ceotto et al., 2009
A.F.S. Duarte et al. / Food Control 32 (2013) 313e321 315to staphylococcins (Bastos et al., 2009), was used as the target
micro-organism in this assay.
Later, using the same procedure, 30 different Gram-positive
bacteria were used as targets for determination of the spectrum
of activity of each AMS: Lactobacillus casei ATCC 398, Lactobacillus
sakei DSM 20017, Lactococcus lactis subsp. cremoris, L. lactis 2084,
L. lactis NZ 9000, Micrococcus luteus ATCC 4698, Enterococcus fae-
cium E89, Enterococcus faecalis 2758, L. monocytogenes 11/LM,
L. monocytogenes L1/L2a, L. monocytogenes 7898, Listeria innocua
397, L. innocua ATCC 33090, six L. monocytogenes strains (L7, L9, L12,
L29, L30 and L32) isolated from sausages and 11 staphylococcal
strains isolated from cheeses (QFrH2 and QM2), salads (5S9, 6H1b,
13H1 and 13S2), and sausages (Sal12, Sal17, LI1, LI2 and L1N4).
2.4. Effect of proteolytic enzymes and of sodium hydroxide
The effect of trypsin, protease XXIII, pronase, and proteinase K
[SigmaeAldrich (St. Louis, USA); 1 mg ml1 prepared in Tris/HCl
50 mM, pH 8.0 e CaCl2 10 mM], and of 0.2 N NaOH on AMS activity
was determined on solid medium as described by Giambiagi-
deMarvaL et al. (1990).
2.5. DNA isolation and manipulations
The plasmidic DNA of staphylococcal lysates of the AMSþ strains
was isolated as described by Giambiagi-deMarvaL et al. (1990) and
the plasmid proﬁles were analyzed by agarose gel electrophoresis
[0.7% (w/v) prepared in Tris 40 mM, acetate 40 mM and EDTA
1 mM, pH 8.4].
The genomic DNA from the AMSþ strains used in the PCR
reactions and in Southern blotting was isolated as described by
Potter et al. (2009). For Southern blotting, the genomic DNA (1 mg)
was previously digested with the restriction enzymes EcoRI (Invi-
trogen, Carlsbad, USA) or HindIII (Invitrogen) according to the
manufacturer’s recommendations.
2.6. Detection of staphylococcin structural genes by PCR
PCR reactions were performed to detect, in the AMSþ strains, the
presence of the operon aurABCD, and of the genesaucA, sacaA/sacbA,
pepA, epiA, elkA, eciA, nukA, and bsaA2 (the structural genes of aur-
eocin A70, aureocin A53, staphylococcin C55, Pep5, epidermin,
epilancin K7, epicidin 280, nukacin 3299, and Bsa, respectively).
With exception for the latter, the primers used for ampliﬁcation of
each gene and the PCR conditions were essentially those previously
described by Ceotto, Nascimento, Brito, and Bastos (2009). The
presence of the bsaA2 structural gene was assessed using the
primers BsaF (50 eTTAACAGCAGAAGCTATTAAAACTACCAG- 30) and
BsaR (50-ATGGAAAAAGTTCTT GATTTAGACG-30) (A. Potter, unpub-
lished data) in the same conditions, except for the annealing
temperature which was 54 C. The amplicons were analyzed by
agarose gel electrophoresis [1.4% (w/v)], using a 100-bp DNA ladder
(Promega, Madison, USA) as the molecular-weight marker.
2.7. DNA/DNA hybridization assays
To detect the structural genes aurABCD, aucA, sacaA/sacbA, pepA,
epiA, elkA, and eciA, Southern blot hybridizations were performed
using the genomic DNA previously digested with EcoRI, and to
detect nukA, the genomic DNA was digested with HindIII.
The digested genomic DNAs were separated by agarose gel
electrophoresis [0.7% (w/v)] and blotted onto nylon membranes
(Hybond-N; GE Healthcare, Piscataway, USA), using standard
methods as described by Sambrook, Fritsch, and Maniatis (1989).
The amplicon corresponding to each staphylococcin structural genewas puriﬁed by the Wizard SV Gel and PCR Clean-Up System
(Promega) and used as probes. Labeling and DNA/DNA hybridiza-
tions were performed using the Gene Images AlkPhos Direct
Labeling and Detection System (GE Healthcare, Buckinghamshire,
UK) according to the manufacturer’s instructions.
In both types of experiments (PCR and hybridization), the
genomic DNA isolated from the producer strain of each staph-
ylococcin under investigation was used as a positive control.
2.8. Pulsed-ﬁeld gel electrophoresis
The genomic DNAs from strains 4059, 4231, 4244, 5409, and
5580 were typed by pulsed-ﬁeld gel electrophoresis (PFGE).
Bacterial suspensions were included in agarose plugs and treated as
previously described by Nascimento, Santos, Gentilini, Sordelli, and
Bastos (2002). Chromosomal DNA was digested with SmaI (New
England Biolabs, Ipswich, USA). Restriction fragments were sepa-
rated by PFGE in 1% (w/v) agarose gels in a CHEF-DRIII system (Bio-
Rad, Hercules, USA) with pulse times increasing from 2 to 35 s for
21 h at 13 C, with a voltage gradient of 6 V cm1 and 120 angle
(Santos, Teixeira, Fonseca, & Gontijo Filho, 1999). Lambda-ladder
PFGE marker of 50e1000 kb (New England Biolabs) was used as
a molecular weight marker. Analysis of the restriction proﬁles was
performed by visual inspection of the photographic register of the
ethidium bromide stained gels. Strains were considered to be
closely related if they differed by no more than three bands
according to van Belkum et al. (2007).
2.9. Crude hyicin 4244 preparation
The cell-free supernatant was obtained from a 1 l culture of
Staphylococcus hyicus 4244 grown at 37 C for 24 h in BHI, under
shaking (180 rpm), and centrifuged at 10,000g for 15 min at 4 C.
Ammonium sulfate [40% (w/v); Vetec, Rio de Janeiro, Brazil]
was added to the supernatant, which was kept under shaking
for 4 h at 4 C. The antimicrobial substance was precipitated from
the supernatant by centrifugation at 10,000g for 25 min at 4 C,
dissolved in 50 ml phosphate buffer (5 mM, pH 6.5), dialyzed
against the same buffer through a 2000 Da cutoff membrane
and treated at 65 C for 15 min. Antimicrobial activity (AU ml1)
was determined by the agar-well diffusion assay as described by
Coelho et al. (2007).
2.10. Activity of hyicin 4244 against L. monocytogenes and
S. aureus in skimmed milk and in TSB broth
To assess the efﬁcacy of the crude hyicin 4244 preparation in
reducing viable cell counts of S. aureus and L. monocytogenes in
food, the activity of this BLIS against both food pathogens was
tested in skimmed milk. In this experiment, the strains S. aureus
A70 Bac and L. monocytogenes ATCC 19117 were used. The milk
was inoculated with approximately 107 cfu ml1 of each bacterium
(previously grown in TSB broth at 37 C for 18 h). The two milk
samples were divided into two portions: in one, 1000 AU ml1 of
the crude BLIS were added and, in the other, equal volume of
phosphate buffer (5 mM, pH 6.5) was added, as a control without
antimicrobial activity. All samples were incubated at 37 C. At the
desired intervals (0, 2, 4, 6, 8 and 24 h), culture aliquots were
serially diluted in a sterile saline solution and plated in triplicate on
TSB medium. Plates were incubated at 37 C for 48 h and the
average number of colonies was used to calculate the number of
viable cells in cfuml1. Three independent trials were carried out as
above for statistical analysis. The same experiment was also per-
formed in TSB broth.
Fig. 1. Plasmid proﬁle of the BLIS-producing strains (a) and Southern blot hybridiza-
tion using the operon aurABCD, ampliﬁed by PCR, as probe (b). The lanes represent
plasmidic DNA isolated from the following strains: (A) S. aureus MB196 (used as
a negative control and as a plasmid molecular size marker); the positions of molecular
size markers (in kb) are indicated on the left; (B) S. aureus A70 (positive control);
(C) 4059; (D) 4231; (E) 4244; (F) 5409, and (G) 5580.
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All experiments of growth inhibition by hyicin 4244 were
carried out in triplicate, and the means and standard deviations
were calculated with the Excel program (Microsoft Corp., USA).
Statistical analyses were performed using the Student’s t-test of the
statistical program R version 2.15.0 (Lucent Technologies, USA),
considering p < 0.05.
3. Results
3.1. Detection of the AMSþ strains
Forty-seven Staphylococcus spp. strains isolated from milk
samples of animals with bovine mastitis from 33 different Brazilian
dairy herds were tested for AMS production. Fourteen strains
(29.8%) from 11 different herds exhibited antagonistic activity
against C. ﬁmi NCTC 7547. During subsequent tests of AMS
production on solid medium, the strains 643, 4189, 3276, and 3398
proved to be inconstant producers, i.e., the detection of the AMS
was observed in some experiments, but not in others. Therefore,
these four strains were not investigated further. The strains 318,
770, 3699, 4369, and 5475 exhibited inhibition zones between 11
and 18 mm, while the remaining ﬁve strains (4059, 4231, 4244,
5409, and 5580) generated inhibition zones larger than 20 mm.
3.2. Effect of proteolytic enzymes and sodium hydroxide on AMS
activity
All ten AMS tested were resistant to 0.2 N NaOH (Table 2), ruling
out the possibility that the inhibition zones exhibited against the
target strains were due to acids from the producer-strain metabo-
lism. Except for the AMS produced by the strains 3699 and 4244,
the remaining AMS were sensitive to at least one proteolytic
enzyme tested, suggesting their proteinaceous nature, a character-
istic of BLIS. Therefore, from hereafter, the AMS will be considered
as BLIS.
3.3. Plasmid proﬁles
The plasmid proﬁles of the BLISþ staphylococcal strains are also
shown in Table 2. The strains 4244, 5475, and 5580 did not present
any plasmidic DNA. Seven strains showed at least two plasmid
forms. The strains 4059 and 4231 exhibited identical proﬁles
(Fig. 1), showing plasmid forms with sizes similar to those of pRJ6,Table 2
Characteristics of the BLIS-producing staphylococcal strains isolated in this study.
BLIS-producing
strains
Effect of proteolytic enzymes (1 mg ml1)b
Protease XXIII Pronase Trypsin
318 S S S
770 R S R
3699 R R R
4059 R R S
4231 S S S
4244 R R R
4369 S S S
5409 R S R
5475 R S S
5580 R S R
A70a S S S
e, Absence of plasmid forms.
SC, supercoiled.
a Strain A70 was included as a control.
b S, sensitivity to proteolytic enzyme; R, resistance to either proteolytic enzyme or Nathe bacteriocinogenic staphylococcal plasmid that encodes aur-
eocin A70. The remaining strains exhibited plasmid proﬁles which
were distinct from each other and that included large and/or small
forms.
3.4. Spectrum of activity of the BLIS produced by the staphylococcal
strains
In order to determine the antimicrobial spectrum of the BLIS
under study, 30 strains, including LAB, food-borne pathogens and
bacterial strains isolated from different foods, were used as targets
(Table 3). The strains 318, 770, 3699, and 4369 did not inhibit any of
these micro-organisms, but only C. ﬁmi NCTC 7547, while the strain
5475 exhibited antimicrobial activity only against M. luteus ATCC
4698.
Except for the two enterococcal, one listerial and two staphy-
lococcal strains, BLIS 4059 and 4231 inhibited all the target strains
used. BLIS 5409 was able to inhibit strains of different genera, but
did not show activity against any staphylococcal strain. The BLIS
produced by the strain 5580 exhibited activity against most (63.3%)NaOH (0.2 N)b Plasmid proﬁle (size in kb)
Proteinase K
S R 4.5; 2.8
R R 18.5; 13.0; 8.0; 6.1; 4.4; 3.0
R R >20.0 (2 forms); 15.0; 14.0;
11.5; 8.0; 5.1; 4.4; 3.1
S R 14.0; 12.0; 8.3
S R 14.2; 12.0; 8.3
R R e
R R 7.1; 3.9; 2.5
S R 5.4; 3.4
S R e
R R e
S R 7.9 (SC form of pRJ6)
OH.
Table 4
Immunity/resistance to bacteriocins among BLIS-producing staphylococcal strains.
Target strains BLIS-producing strains
4059 4231 4244 5409 5580
S. aureus A53 þþ þþ þþ þ þ
S. aureus A70   þþþ  þ
S. aureus A70 Bac þþ þþ þþþ  þ
S. aureus C55 þ þ þþ  
S. epidermidis 5 þ þ þþ  
S. epidermidis 5 Bac þ þþ þþ  
S. epidermidis Tü3298   þ  
S. epidermidis BN280   þ  
S. epidermidis K7   þþþ  
S. simulans 3299 þþ þþ þþ  
S. aureus COL1881   þþþ  
Producer strains (bacteriocin) Target strains
4059 4231 4244 5409 5580
S. aureus A53 (aureocin A53) þ þ þ þ 
S. aureus A70 (aureocin A70)     
S. aureus C55 (staphylococcin C55)     
S. epidermidis 5 (Pep5) þþ þ þþ þ 
S. epidermidis Tü3298 (epidermin) þþþ þþþ þþþ þþþ þþþ
S. epidermidis BN280 (epicidin 280)     
S. epidermidis K7 (epilancin K7)     
S. simulans 3299 (nukacin 3299)   þþ þþ 
S. aureus COL1881 (Bsa)     þþþ
(þ) inhibition zones between 12 and 20 mm; (þþ) inhibition zones between 21 and
29 mm; (þþþ) inhibition zones  30 mm; () no inhibition.
Table 3
Spectrum of activity of the BLIS produced by strains of Staphylococcus spp.
Target strains BLIS-producing strains
4059 4231 4244 5409 5580
L. casei ATCC 398 þþ þþ þþþ þþ 
L. sakei DSM 20017 þþ þþ þþþ þþ 
L. lactis subsp. cremoris þþ þþ þþþ þþ þþ
L. lactis NZ 9000 þþ þþ þþþ þþ þþ
L. lactis 2084 þþ þþ þþþ þþ þþ
M. luteus ATCC 4698 þþ þþ þþþ  þþ
E. faecium E89   þþþ  þþ
E. faecalis 2758   þþ  
L. monocytogenes 11/LM þþ þþ þþþ  
L. monocytogenes L1/L2a þþ þþ þþ þþ 
L. monocytogenes 7898 þþ þþ þþ  
L. innocua 397 þþ þþ þþþ þþ 
L. innocua ATCC 33090 þþ þþ þþþ  
L. monocytogenes L7 þþ þþ þþþ  
L. monocytogenes L9 þþ þþ þþ  
L. monocytogenes L12 þþ þþ þþ  
L. monocytogenes L29 þþ þþ þþþ  
L. monocytogenes L30 þþ þþ þþþ  
L. monocytogenes L32 þþ þþ þþþ  
Staphylococcus spp. QRFH2  þþ þþþ  
Staphylococcus spp. QM2   þþ  
Staphylococcus spp. 5S9   þþþ  
Staphylococcus spp. 6H1b   þþ  þþ
Staphylococcus spp. 13H1   þþ  
Staphylococcus spp. 13S2   þþ  
Staphylococcus spp. Sal12   þþ  
Staphylococcus spp. Sal17   þþþ  
Staphylococcus spp. LI1 þþ þþ þþ  
Staphylococcus spp. LI2   þþþ  
Staphylococcus spp. L1N4   þþ  
(þ) inhibition zones between 12 and 20 mm; (þþ) inhibition zones between 21 and
29 mm; (þþþ) inhibition zones  30 mm; () no inhibition. Only the producer
strains that inhibited more than one of the target strains are shown in this table.
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trum of activity, inhibiting all 30 targets tested.
Based on the results shown above, only the strains 4059, 4231,
4244, 5409, and 5580 were selected for further analyses. According
to API and additional identiﬁcation tests, strains 4059 and 4231
were identiﬁed as S. aureus, 4244 and 5409 as S. hyicus, and 5580 as
S. epidermidis. Since the BLIS produced by strain 4244 exhibited
a broader potential biotechnological application, the identiﬁcation
of strain 4244 as S. hyicus was conﬁrmed by 16S rDNA sequencing.
3.5. Cross-immunity against bacteriocins produced by S. aureus,
S. epidermidis and S. simulans
Bacteriocin-producing bacteria normally possess a mechanism
of immunity to protect themselves from their own products, and
such self-immunity is often mediated by the expression of
a cognate immunity system. Generally, strains that produce either
identical or similar bacteriocins exhibit cross-immunity (Jack et al.,
1995). Therefore, the inhibitory activity of the BLISþ strains inves-
tigated in the present study was tested against staphylococcal
strains which produce known staphylococcins and vice-versa. The
results of these cross-immunity tests are shown in Table 4.
Strains 4059 and 4231 were able to inhibit the growth of
S. aureus A70 Bac (cured of the plasmid pRJ6) but not of strain A70,
the aureocin A70 producer. Furthermore, strain A70 did not inhibit
the strains 4059 and 4231, suggesting the presence of cross-
immunity among the AMS produced by these three strains and,
therefore, the relatedness among them.
The producer strain of epidermin, aureocin A53, and Pep5 were
able to inhibit all ﬁve Staphylococcus spp. associated with bovine
mastitis, suggesting that none of the BLIS from this study isidentical to these three staphylococcins. The BLIS produced by
strain 4244 inhibited all nine staphylococcin-producing strains,
suggesting that this BLIS is distinct from these nine staphylococcins
described in the literature.
The strain 5409 inhibited the producer strain S. aureus A53 and
was sensitive to the bacteriocins aureocin A53, Pep5, epidermin,
and nukacin 3299, suggesting that BLIS 5409 is different from these
four staphylococcins. Additionally, the strain 5580 was inhibited by
epidermin and Bsa, and was able to inhibit the producer strains of
aureocins A53 and A70, suggesting that BLIS 5580 was not similar
to these four bacteriocins.
3.6. Detection of staphylococcin structural genes by PCR and DNA/
DNA hybridizations
The ﬁve BLIS-producer strains were then tested for the presence
of the structural genes involved in production of aureocin A70,
aureocin A53, staphylococcin C55, Pep5, epidermin, epicidin 280,
epilancin K7, and nukacin 3299 by both PCR and DNA/DNA hybrid-
izations, and for the presence of the Bsa structural gene only by PCR.
By using speciﬁc primers for detection of the operon aurABCD
(coding for the structural genes of aureocin A70), a w500 bp
fragment was ampliﬁed in the strains 4059 and 4231 (Fig. 2). In
hybridization assays using the operon aurABCD as probe, signals
were detected in both strains on plasmids with w8.0 kb, a size
similar to that of pRJ6 (Fig. 1).
The remaining three strains which did not present the aurABCD
operon were tested for the presence of the structural genes aucA,
sacaA/sacbA, pepA, eciA, elkA, epiA, nukA, and bsaA2 but none of
these genes could be detected on the 4244 and 5580 genomes (data
not shown). These results suggest that the strains 4244 and 5580
produce BLIS which are distinct from nine staphylococcins already
described in the literature. However, the presence of the structural
genes of epidermin and Bsa was detected in strain 5409 through
ampliﬁcation of fragments with approximately 430 and 150 bp, the
size expected for the amplicons corresponding to the epiA and
bsaA2 genes, respectively. However, the observed DNA bands for
strain 5409 were weaker than those observed for the positive
controls (data not shown).
Fig. 3. DNA banding patterns obtained by PFGE of genomic DNA digested with SmaI.
(A) S. aureus A70; (B) 4059; (C) 4231; (D) 4244; (E) 5409, and (F) 5580.
Fig. 2. DNA banding patterns obtained after PCR ampliﬁcation with speciﬁc primers
for detection of the operon aurABCD. (A) 100-bp DNA ladder (Invitrogen); the positions
of molecular size markers (in kb) are indicated on the left; (B) S. aureus A70 (positive
control); (C) 4059; (D) 4231; (E) 4244; (F) 5409; (G) 5580, and (H) S. aureus A53
(negative control).
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Genomic DNA from the BLISþ strains was typed by PFGE after
digestionwith SmaI to determine strain similarity. According to the
results shown in Fig. 3, strains 4059 (lane B) and 4231 (lane C),
isolated from milk of cows of the same herd, exhibited identical
PFGE proﬁles showing that they are the same isolate. However,
comparison of the banding patterns of these two strains with the
banding pattern of S. aureus A70 (the producing strain of aureocin
A70) showed that the latter strain exhibited a quite distinct proﬁle
(lane A). The other three strains exhibited clearly different proﬁles,
even both S. hyicus strains (lanes D and E), which prove to be
distinct isolates of this staphylococcal species. The S. hyicus strains
were isolated from different dairy herds.
3.8. Activity of hyicin 4244 against L. monocytogenes and S. aureus
in skimmed milk and in TSB broth
In order to test the potential application of hyicin 4244 as a food
biopreservative, 1000 AU ml1 of a crude preparation of this BLIS
were added to skimmed milk samples previously inoculated with
approximately 7 log cfu ml1 of either L. monocytogenes ATCC 19117
or S. aureus A70 Bac. Additionally, this experiment was also per-
formed in TSB broth.
L. monocytogenes grew in skimmed milk from an initial count of
7e8 log cfu ml1 after 24 h at 37 C (Fig. 4B). However, in the milk
addedof 1000AUml1 of hyicin4244 thebacteria countswere lower
than the counts detected in the growth control (p< 0.05), remaining
the same as the initial inoculum. This result suggests an inhibitory
action of hyicin 4244 in this food matrix. Similar results were found
in TSB broth contaminated with L. monocytogenes (Fig. 4A).
In TSB broth, S. aureus viable counts increased from an initial
value of 7e9 log cfu ml1 during 8 h at 37 C, followed by a slight
decrease after 24 h of incubation (Fig. 4C). The addition of hyicin
4244 to TSB resulted in signiﬁcant reduction (p < 0.05) in S. aureus
counts compared with those of the control. It was observed that the
bacterial growth remained below 7 log cfu ml1 during cultivation
for 24 h in TSB. Similar results were obtained in skimmed milk
inoculated with 7 log cfu ml1 of S. aureus (Fig. 4D). However, after24 h of incubation, there was a slight increase in S. aureus counts,
possibly due to loss of hyicin 4244 efﬁcacy brought about by such
factors as binding of the BLIS to the food matrix and insufﬁcient
AMS concentration.
4. Discussion
Bacteriocins have been effectively characterized and tested in
food systems to control pathogenic and spoilage micro-organisms,
being studied as natural additives in the food industry (Bastos &
Ceotto, 2010; Gálvez, López, Abriouel, Valdivia, & Omar, 2008).
Fig. 4. L. monocytogenes and S. aureus growth kinetics either in the presence (squares) or in the absence (circles) of 1000 AUml1 of hyicin 4244. The curves show viable cell counts
(cfu/ml). A and B, L. monocytogenes growth kinetics in TSB medium and skimmed milk, respectively. C and D, S. aureus growth kinetics in TSB medium and skimmed milk,
respectively.
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to date, the only commercially available bacteriocins are nisin, and,
to a lesser extent, pediocin PA-1 (Cotter, Hill, & Ross, 2005). Because
nisin is shown to be ineffective in some food matrices (e.g. meat),
and considering the potential emergence of nisin-resistant bacte-
rial populations, it seems attractive to explore the use of other
bacteriocins to prevent microbial growth in food products (Deegan,
Cotter, Hill, & Ross, 2006).
Previous studies from our group have described the isolation of
bacteriocin-producing staphylococcal strains of different sources in
Brazil (Bastos et al., 2009; Ceotto et al., 2009). In the present study,
amongst 47 Staphylococcus spp. strains isolated from milk from
mastitic cattle, 14 strains (29.8%) were shown to produce AMS, but
only ﬁve (10.6%) exhibited a high antagonistic activity against
C. ﬁmi.
The main criterion established to characterize AMS as bacte-
riocins is the presence of a biologically active proteinaceous
compound (Cascales et al., 2007; Jack et al., 1995). The AMS
produced bymost strains tested in the present study were sensitive
to at least one proteolytic enzyme suggesting that they might be
BLIS. The exceptions were BLIS 3699 and BLIS 4244. However,
bacteriocins resistant to proteolytic digestion have already been
reported in the literature, such as aureocin A53 (Netz et al., 2002).
Among the ﬁve staphylococcal strains that exhibited the
broadest antimicrobial spectra of activity, strains 4244 and 5580
carry no plasmidic DNA, suggesting that the genes coding for their
corresponding BLIS are located on the bacterial chromosome. Two
plasmid forms were observed in strain 5409. However, its bacte-
riocin genetic determinants are probably chromosomally encoded
since the plasmid forms found in this strain (5.4 and 3.4 kb) may
represent the OC and SC forms of the same plasmid, which is toosmall to carry all genes generally required for bacteriocin expres-
sion (Bierbaum & Sahl, 2009; Nissen-Meyer, Rogne, Oppegård,
Haugen, & Kristiansen, 2009).
The S. aureus strains 4059 and 4231 showed three plasmid forms
with sizes similar to those of pRJ6, a 7.9-kb plasmid which encodes
aureocin A70 (Coelho, Ceotto, Madureira, Nes, & Bastos, 2009).
Cross-immunity tests against S. aureus A70 and its derivative A70
Bac and detection of the aurABCD operon by PCR and DNA/DNA
hybridization conﬁrmed that strains 4059 and 4231 produce a BLIS
either similar or identical to aureocin A70, whose genetic deter-
minants are present on their single plasmid. Nevertheless, the PFGE
proﬁles of both strains proved to be identical to each other but
distinct from the banding pattern of S. aureus A70, conﬁrming that
the genes involved in aureocin A70 production can be found in
genetically-unrelated strains of S. aureus, as already proposed by
Ceotto et al. (2012).
Giving that BLIS 4059 was shown to be resistant to protease
XXIII and pronase digestion, while aureocin A70 was sensitive, it
can be assumed that BLIS 4059 is a more resistant variant of aur-
eocin A70, which can give to the former an advantage when
considering its application in food with high enzymatic activity,
such as meats (Gálvez et al., 2007).
In relation to strains 4244 and 5580, the immunity/resistance,
PCR and DNA/DNA hybridization experiments showed that they
produce BLIS which seem to be different from nine staphylococcins
described in the literature: aureocins A70 and A53, staphylococcin
C55, Pep5, epidermin, epicidin 280, epilancin K7, nukacin 3299/ISK-
1, and Bsa.
The BLIS-producing strains 4244 and 5409 were identiﬁed as
S. hyicus and 5580 as S. epidermidis. So far, there are ﬁve staph-
ylococcins produced by S. epidermidis described in the literature:
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epidermicin NI01 (Bastos et al., 2009; Sandiford & Upton, 2012).
Like epilancin K7, BLIS 5580 seems also to be chromosomally
encoded. However, as already mentioned above, our data suggest
that BLIS 5580 is different from epilancin K7.
Strain 5409 showed sensitivity to epidermin. However, weak
bands were observed for this strain during amplication of both epiA
and bsaA2 genes. These results suggest that strain 5409 may
produce an epidermin-like bacteriocin. Although similar bacterio-
cins generally exhibit cross-immunity, Daly et al. (2010) observed
that strain 26, a Bsa (an epidermin-like bacteriocin) producer, was
also inhibited by epidermin.
Hyicin 4244, the BLIS produced by S. hyicus 4244, showed the
broadest spectrum of activity, inhibiting all bacterial strains used as
targets, including important food-borne pathogens such as
L. monocytogenes and S. aureus isolated from different types of food.
Furthermore, hyicin 4244was able to inhibit the growth of S. aureus
and L. monocytogenes in TSB medium and in skimmed milk during
incubation for 24 h at 37 C. Taken together, these results suggest
that this BLIS possesses potential application in food preservation.
Although nisin is already employed as a food preservative in
more than 50 countries, it exhibits a low stability in either neutral
or alkaline pH which limits its use (Bastos & Ceotto, 2010). More-
over, its continuous use may lead to emergence of resistant
mutants, as already reported in the literature (Cotter et al., 2005).
Therefore, the search for new bacteriocins, such as hyicin 4244, that
compensate for the nisin instability but with a broad spectrum of
activity, may play a beneﬁcial role in the control of undesirable
microbial populations.
Recently, a bacteriocin produced by S. hyicus (hyicin 3682), and
related to both epidermin and Bsa, has been described (Fagundes
et al., 2011). However, hyicin 4244 seems to be distinct from hyi-
cin 3682 due to its resistance to proteolytic enzymes and to the fact
that the producer strains of each hyicin were able to inhibit each
other (data not shown). Moreover, hyicin 4244 seems to be
different from both Bsa and epidermin.
Due to hyicin 4244 broad spectrum of activity, its puriﬁcation
and detailed chemical and genetic characterization are currently in
progress. Moreover, the investigation of its kinetics of activity will
be also of great importance to further application of this new
staphylococcin as a biopreservative in a food matrix, either alone or
combined with other preservation techniques. In a near future,
hyicin 4244 gene cluster could also be expressed in nonpathogenic
food-grade CoNS species, such as Staphylococcus xylosus and
Staphylococcus carnosus, which play important roles in food tech-
nology, maximizing food protection against undesirable micro-
organisms.
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